Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
SHC Transcript
Sotera Health Company (SHC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Neutral1-12
Sotera Health Company (SHC) Q3 2025 Earnings Call Transcript
Positive11-4
The earnings call reveals strong financial metrics, including raised revenue and EBITDA growth outlooks, improved net leverage ratio, and increased adjusted EPS guidance. Despite some concerns, such as margin compression and Q4 pullback, the overall sentiment is positive, with consistent performance across key areas and confidence in long-term growth. The market cap suggests moderate volatility, leading to a positive stock price prediction (2%-8%) over the next two weeks.
Sotera Health Company (SHC) Q2 2025 Earnings Call Transcript
Positive8-8
The earnings call summary and Q&A indicate stable financial performance, with positive operating cash flow and improved net leverage ratio. Despite limited guidance for 2026, there is optimism in product development and market strategy, particularly with Sterigenics and Nelson Labs. The company's strong liquidity position and ongoing investments in capacity expansion further support a positive outlook. Given the market cap of approximately $3.37 billion, the stock is likely to experience a moderate positive reaction in the range of 2% to 8% over the next two weeks.
Sotera Health Company (SHC) Q1 2025 Earnings Call Transcript
Unknown5-2
The earnings call presents a mixed picture: positive financial performance with strong revenue growth in some segments and improved margins, but also challenges like a net loss and declining revenue in Nelson Labs. The Q&A reveals optimism about future growth and margin improvements, yet there are uncertainties regarding legal risks and regulatory outcomes. The market cap suggests moderate reaction, and the absence of strong catalysts like new partnerships or significant guidance changes leads to a neutral prediction for stock movement.
SHC Slides
SHC Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
